Labwire, Inc. (LBWR) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Labwire, Inc. (LBWR) trades at $0.0004 with AI Score 42/100 (Grade C). Labwire, Inc. provides employee screening services to Fortune 500 corporations. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for LBWR: LBWR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LBWR against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
LBWR: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Labwire, Inc. (LBWR) Financial Services Profile
Labwire, Inc. offers employee screening services, including drug testing and background checks, primarily targeting Fortune 500 corporations through its Labwire Platform. The company operates in the shell companies industry within the financial services sector, providing regulatory compliance and data management solutions for workplace screening.
What Is the Investment Thesis for LBWR?
Labwire, Inc. presents a focused business model within the employee screening services sector, targeting large corporations with its Labwire Platform. The company's ability to streamline regulatory compliance and data management for Fortune 500 companies could drive revenue growth. However, the company's market capitalization is $0.00B, and the beta is -123.31, indicating high volatility and potential risk. The absence of dividends may deter some investors. Growth hinges on expanding its client base and enhancing its platform's capabilities to meet evolving regulatory requirements. The company's small size and limited resources may pose challenges in competing with larger, more established players in the industry. Investors should carefully assess the company's financial stability and growth prospects before considering an investment.
Based on FMP financials and quantitative analysis
LBWR Key Highlights
Labwire, Inc. provides employee screening services, including drug testing and background checks.
- The company's primary offering is the Labwire Platform, a web-based application for streamlining regulatory and record management.
- Labwire focuses on serving Fortune 500 corporations in the United States.
- The company's market capitalization is $0.00B.
- Labwire does not offer a dividend.
Who Are LBWR's Competitors?
LBWR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
| INACU Indigo Acquisition Corp. | $12.08 | +16.94% | $34.9M | 60 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
| RCLFU Rosecliff Acquisition Corp I | $11.33 | +11.74% | $77.2M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LBWR's Key Strengths?
Specialized focus on employee screening services.
- Web-based Labwire Platform for efficient data management.
- Experience serving Fortune 500 corporations.
- Comprehensive service offerings, including drug testing and background checks.
What Are LBWR's Weaknesses?
Small company size with limited resources (2 employees).
- Dependence on a specific niche market (Fortune 500 corporations).
- Potential vulnerability to changes in regulations or industry standards.
- Limited brand recognition compared to larger competitors.
What Are the Key Risks for LBWR?
Financial-distress signal — its Altman Z-Score of -2.41 sits in the distress zone (elevated bankruptcy risk).
- Limited financial resources and small company size may hinder growth and competitiveness.
- Dependence on a specific niche market (Fortune 500 corporations) could limit growth opportunities.
- Changes in regulations or legal standards could impact the demand for employee screening services.
- Economic downturns could reduce corporate spending on employee screening.
- Trading on the OTC Other tier carries significant risks due to limited disclosure and liquidity.
What Are the Growth Opportunities for LBWR?
- Expansion of Service Offerings: Labwire could expand its service offerings to include additional screening services, such as mental health assessments or specialized background checks tailored to specific industries. The market for specialized screening services is growing, driven by increasing awareness of workplace safety and well-being. By offering a broader range of services, Labwire could attract new clients and increase revenue from existing customers. Timeline: 1-2 years.
- Geographic Expansion: Labwire could expand its geographic reach beyond the United States to serve multinational corporations with operations in other countries. The global employee screening market is substantial, and Labwire's platform could be adapted to meet the regulatory requirements of different countries. This expansion would require investment in localization and compliance expertise. Timeline: 2-3 years.
- Strategic Partnerships: Labwire could form strategic partnerships with HR software providers or other companies that serve the human resources market. These partnerships could provide Labwire with access to a broader customer base and enhance its distribution channels. The market for HR technology is growing rapidly, and partnerships could accelerate Labwire's growth. Timeline: 1 year.
- Enhancement of Labwire Platform: Labwire could invest in enhancing the capabilities of its Labwire Platform to include features such as artificial intelligence-powered risk assessment or automated compliance updates. The market for AI-powered HR solutions is growing, and these enhancements could differentiate Labwire from its competitors. Timeline: Ongoing.
- Focus on Small and Medium-Sized Businesses (SMBs): While Labwire currently focuses on Fortune 500 corporations, it could expand its target market to include SMBs. The SMB market is substantial, and many SMBs lack the resources to implement comprehensive employee screening programs. Labwire could develop a simplified version of its platform tailored to the needs of SMBs. Timeline: 2 years.
What Are LBWR's Competitive Advantages?
- Proprietary Labwire Platform: The web-based application streamlines regulatory and record management activities.
- Established relationships with Fortune 500 corporations.
- Expertise in regulatory compliance related to employee screening.
- Customized service offerings tailored to specific client needs.
What Does LBWR Do?
Founded in 2004 and headquartered in Brookshire, Texas, Labwire, Inc., along with its subsidiary, Workplace Screening Services, specializes in providing comprehensive employee screening solutions. The company's core offering is the Labwire Platform, a web-based application designed to streamline and manage the complex regulatory and record-keeping requirements associated with employee screening processes. Labwire's services encompass a wide range of solutions, including drug testing, employee background screening, drug testing policy analysis and updates, medical review, supervisor training and education, and real-time online data management. Labwire assists organizations with customized services, including education, client support systems, background checks, and physicals. The company's Labwire application services facilitate data management and transmission, collection site management and billing consolidation, and custom statistical reports and data transfer. Labwire focuses on serving Fortune 500 corporations in the United States, positioning itself as a provider of regulatory compliance and efficient data management in the employee screening domain. The company's solutions are designed to help businesses maintain safe and compliant workplaces while minimizing administrative burdens.
What Products and Services Does LBWR Offer?
- Provides employee drug testing services.
- Offers employee background screening services.
- Conducts drug testing policy analysis and updates.
- Provides medical review services.
- Offers supervisor training and education programs.
- Provides real-time online data management through Labwire Platform.
- Offers Red Flag Compliance program and drug testing program development.
- Assists organizations with customized education, client support systems, background checks, and physicals.
How Does LBWR Make Money?
- Offers subscription-based access to the Labwire Platform.
- Charges fees for individual employee screening services, such as drug tests and background checks.
- Provides customized consulting services related to employee screening program development and compliance.
- Generates revenue through data management and transmission services.
What Industry Does LBWR Operate In?
Labwire, Inc. operates within the employee screening services industry, which is driven by increasing regulatory compliance requirements and the need for businesses to maintain safe and productive workplaces. The market includes various players offering similar services, ranging from large, established companies to smaller, specialized firms. The industry is influenced by factors such as employment rates, drug use trends, and evolving legal standards. Labwire's focus on technology-driven solutions and its emphasis on serving Fortune 500 corporations position it within a specific niche of the broader employee screening market.
Who Are LBWR's Key Customers?
- Fortune 500 corporations.
- Companies in various industries requiring employee screening services.
- Organizations seeking regulatory compliance in employee screening.
- Businesses needing efficient data management for employee screening records.
Financial Health
Labwire, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.41 places it in the distress zone, a signal of elevated financial risk.
LBWR Valuation & Market Position
Relative to its peer group, LBWR's quantitative score of 42/100 is below the peer average of 63/100.
Key Financial Metrics
Return on equity for Labwire, Inc. stands at 0.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Labwire, Inc. operates in the Information Technology Services industry within the Technology sector. It is headquartered in Phoenix, US. The company is led by CEO Shin Hwang. LBWR has traded publicly since 2009.
LBWR Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on employee screening services.
- Web-based Labwire Platform for efficient data management.
- Experience serving Fortune 500 corporations.
- Comprehensive service offerings, including drug testing and background checks.
Bear Case
- Small company size with limited resources (2 employees).
- Dependence on a specific niche market (Fortune 500 corporations).
- Potential vulnerability to changes in regulations or industry standards.
- Limited brand recognition compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
LBWR Latest News
No recent news available for LBWR.
LBWR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LBWR.
Price Targets
Wall Street price target analysis for LBWR.
LBWR MoonshotScore
What does this score mean?
The MoonshotScore rates LBWR 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Shell CompaniesLeadership: Shin Hwang
Unknown
Information about Shin Hwang's background is not available in the provided data. Without further information, it is not possible to provide details about their career history, education, or previous roles.
Track Record: Information about Shin Hwang's track record is not available in the provided data. Without further information, it is not possible to provide details about key achievements, strategic decisions, or company milestones under their leadership.
LBWR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Labwire, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited or no financial disclosure, making it difficult to assess the company's financial health.
- Low trading volume and wide bid-ask spreads, leading to illiquidity and price volatility.
- Potential for price manipulation due to the lack of regulatory oversight.
- Higher risk of fraud or other illegal activities compared to companies listed on major exchanges.
- Limited access to capital and difficulty raising funds.
- Verify the company's legal status and registration.
- Attempt to obtain and review any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC Other tier stocks.
- Consult with a qualified financial advisor before investing.
- Check for any regulatory actions or legal proceedings involving the company.
- Company has been in operation for several years (founded in 2004).
- Company provides a specific service (employee screening) to a defined market (Fortune 500 corporations).
- Company has a website and contact information.
- Company has a subsidiary (Workplace Screening Services).
- Company offers a technology platform (Labwire Platform).
What Investors Ask About Labwire, Inc. (LBWR) — Financial Services
What does the AI Score mean for LBWR?
LBWR holds an AI Score of 42/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Labwire, Inc. provides employee screening services to Fortune 500 corporations. It operates through its Labwire Platform, a web-based application designed to streamline regulatory and record …
What does Labwire, Inc. do?
Labwire, Inc. specializes in providing employee screening services, primarily targeting Fortune 500 corporations. The company offers a comprehensive suite of solutions, including drug testing, employee background screening, and regulatory compliance management through its web-based Labwire Platform. This platform streamlines data management and reporting for businesses, ensuring adherence to industry standards and regulations. Labwire's services help organizations maintain safe and compliant workplaces by efficiently managing the complexities of employee screening processes.
What are the main risks for LBWR?
Labwire, Inc. faces several risks, including its small size and limited resources, which may hinder its ability to compete with larger, more established players in the employee screening services market. The company's dependence on Fortune 500 corporations makes it vulnerable to economic downturns and changes in corporate spending. Furthermore, the evolving regulatory landscape and potential cybersecurity threats pose ongoing challenges.
What regulatory challenges does Labwire, Inc. face?
Labwire, Inc. operates in a highly regulated environment, facing numerous federal and state laws related to employee screening, data privacy, and workplace safety. Compliance with regulations such as the Fair Credit Reporting Act (FCRA) and various drug testing regulations is critical. Changes in these regulations could require Labwire to adapt its services and platform, potentially incurring significant costs.
What are the key factors to evaluate for LBWR?
Labwire, Inc. (LBWR) holds an AI score of 42/100 (low). presents a focused business model within the employee screening services sector, targeting large corporations with its Labwire Platform. Not financial advice.
How frequently does LBWR data refresh on this page?
LBWR's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven LBWR's recent stock price performance?
Labwire, Inc. (LBWR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on employee screening services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LBWR overvalued or undervalued right now?
Labwire, Inc. (LBWR) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research LBWR before investing?
Before investing in Labwire, Inc. (LBWR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for this OTC-traded company.
- AI analysis pending, which may provide further insights.